Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerie Jakrot

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Histopathology|June 22, 2012
Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanomaJames Wilmott, Lauren Haydu, Martine Bagot, et al.
Pathology|September 11, 2013
BAP1 expression in cutaneous melanoma: a pilot studyRajmohan Murali, James S Wilmott, Valerie Jakrot, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2019
Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 DiabetesVenessa H M Tsang, Rachel T McGrath, Roderick J Clifton-Bligh, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2020
Response to Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes"Venessa H M Tsang, Rachel T McGrath, Roderick J Clifton-Bligh, et al.
Clinical & Experimental Metastasis|January 18, 2014
Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patientsKimberley L Kaufman, Swetlana Mactier, Nicola J Armstrong, et al.
Pathology|October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomesJames S Wilmott, Matthew A Field, Peter A Johansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2017
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in MelanomaRicardo E Vilain, Alexander M Menzies, James S Wilmott, et al.
The Australasian Journal of Dermatology|April 29, 2022
Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (MelCOR): A modified Delphi studyDale Jobson, Benjamin Roffey, Christopher Arnold, et al.
Cancer Immunology Research|March 6, 2021
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient SurvivalNicholas A Gherardin, Kelly Waldeck, Alex Caneborg, et al.
Scientific Data|August 14, 2024
The SLICE-3D dataset: 400,000 skin lesion image crops extracted from 3D TBP for skin cancer detectionNicholas R Kurtansky, Brian M D'Alessandro, Maura C Gillis, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Histopathology|June 22, 2012
Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanomaJames Wilmott, Lauren Haydu, Martine Bagot, et al.
Pathology|September 11, 2013
BAP1 expression in cutaneous melanoma: a pilot studyRajmohan Murali, James S Wilmott, Valerie Jakrot, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2019
Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 DiabetesVenessa H M Tsang, Rachel T McGrath, Roderick J Clifton-Bligh, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2020
Response to Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes"Venessa H M Tsang, Rachel T McGrath, Roderick J Clifton-Bligh, et al.
Clinical & Experimental Metastasis|January 18, 2014
Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patientsKimberley L Kaufman, Swetlana Mactier, Nicola J Armstrong, et al.
Pathology|October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomesJames S Wilmott, Matthew A Field, Peter A Johansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2017
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in MelanomaRicardo E Vilain, Alexander M Menzies, James S Wilmott, et al.
The Australasian Journal of Dermatology|April 29, 2022
Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (MelCOR): A modified Delphi studyDale Jobson, Benjamin Roffey, Christopher Arnold, et al.
Cancer Immunology Research|March 6, 2021
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient SurvivalNicholas A Gherardin, Kelly Waldeck, Alex Caneborg, et al.
Scientific Data|August 14, 2024
The SLICE-3D dataset: 400,000 skin lesion image crops extracted from 3D TBP for skin cancer detectionNicholas R Kurtansky, Brian M D'Alessandro, Maura C Gillis, et al.
Pageof 2